Johan Kolmert

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.

First-in-human (phase I) trial of SOL-116, a humanised IgG4 monoclonal antibody targeting bile salt-stimulated lipase, in healthy participants and rheumatoid arthritis patients.

Journal: RMD open

Published: January 09, 2026

IL-33 enhances responsiveness and mast cell mediator release in isolated human small airways.

IL-33 enhances responsiveness and mast cell mediator release in isolated human small airways.

Journal: The Journal of allergy and clinical immunology

Published: November 20, 2025

IgE-activated human lung mast cells preferentially release prostaglandin D2, thromboxane A2, and cysteinyl-leukotrienes.

IgE-activated human lung mast cells preferentially release prostaglandin D2, thromboxane A2, and cysteinyl-leukotrienes.

Journal: The Journal of allergy and clinical immunology

Published: April 11, 2025

Eicosanoid metabolites in relation to non-small cell lung cancer.

Eicosanoid metabolites in relation to non-small cell lung cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 20, 2025

COMSA-MEWS: a simple quantitative algorithm for determining response to biologics in severe asthma, tested in a real-world mepolizumab study.

COMSA-MEWS: a simple quantitative algorithm for determining response to biologics in severe asthma, tested in a real-world mepolizumab study.

Journal: ERJ open research

Published: January 07, 2025

Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma.

Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthma.

Journal: ERJ open research

Published: October 21, 2024

High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma.

High-Dimensional Analysis of Type 2 Lymphocyte Dynamics During Mepolizumab or Dupilumab Treatment in Severe Asthma.

Journal: Allergy

Published: October 08, 2024

Prenatal Fish Oil Supplementation, Maternal COX1 Genotype, and Childhood Atopic Dermatitis: A Secondary Analysis of a Randomized Clinical Trial.

Prenatal Fish Oil Supplementation, Maternal COX1 Genotype, and Childhood Atopic Dermatitis: A Secondary Analysis of a Randomized Clinical Trial.

Journal: JAMA dermatology

Published: August 28, 2024

Impact of Short-Term Diesel Exhaust Exposure on Prothrombotic Markers in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Crossover Study.

Impact of Short-Term Diesel Exhaust Exposure on Prothrombotic Markers in Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Crossover Study.

Journal: Annals of the American Thoracic Society

Published: August 21, 2024

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.

Biomarker Predictors of Clinical Efficacy of the Anti-IgE Biologic Omalizumab in Severe Asthma in Adults: Results of the SoMOSA Study.

Journal: American journal of respiratory and critical care medicine

Published: April 18, 2024

Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics.

Radiomultiomics: quantitative CT clusters of severe asthma associated with multiomics.

Journal: The European respiratory journal

Published: February 01, 2024

Urinary eicosanoid levels in early life and risk of atopic disease in childhood.

Urinary eicosanoid levels in early life and risk of atopic disease in childhood.

Journal: The Journal of allergy and clinical immunology

Published: November 17, 2023

Showing 1-12 of 39

Last Updated: 09/26/2026